The development of biomarkers for early cancer diagnosis holds significant promise in improving patient outcomes and transforming cancer care. Overall, the perspectives in developing biomarkers for early cancer diagnosis are focused on leveraging advancements in genomics, molecular profiling, non-invasive techniques, computational analysis, and collaborative research to enhance early detection, improve diagnostic accuracy, and enable personalized treatment approaches. Continued investment in research and technology development, along with regulatory support, will be key to realizing the full potential of biomarkers in cancer care.